Supplemental material
Expert Opinion on Biological Therapy
Volume 23, 2023 - Issue 8: Biosimilars
Original Research
A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea
, 
, , , , , , , , , , , , , & show all
Youngwoo Jeonb Department of Hematology, Lymphoma and Cell Therapy–Research Center, Yeouido St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Koreahttps://orcid.org/0000-0003-3362-8200View further author information
https://orcid.org/0000-0003-3362-8200View further author information, DaJung Kimc Department of Internal Medicine, Kosin University College of Medicine, Kosin University, Seo-gu, Busan, Republic of Koreahttps://orcid.org/0000-0003-2375-8140View further author information
https://orcid.org/0000-0003-2375-8140View further author information, , Won Sik Leee Department of Internal Medicine, Hemato-oncology, Inje University Busan Paik Hospital, Busangjin-gu, Busan, Republic of Koreahttps://orcid.org/0000-0002-7956-468XView further author information
https://orcid.org/0000-0002-7956-468XView further author information, , Jun Ho Yig Department of Internal Medicine, Division of Hematology and Oncology, Chung-ang University Hospital, Dongjak-gu, Seoul, Republic of Koreahttps://orcid.org/0000-0003-1499-7131View further author information
https://orcid.org/0000-0003-1499-7131View further author information, , , , , KeumYoung Ahnk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-9370-5338View further author information
https://orcid.org/0000-0002-9370-5338View further author information, TaeHong Parkk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0003-1922-2810View further author information
https://orcid.org/0000-0003-1922-2810View further author information, Hana Juk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-9504-9995View further author information
https://orcid.org/0000-0002-9504-9995View further author information, Soonbum Kwonk Celltrion, Inc., Yeonsu-gu, Incheon, Republic of Koreahttps://orcid.org/0000-0002-0517-8647View further author information
https://orcid.org/0000-0002-0517-8647View further author information & Seok-Goo Chol Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seocho-gu, Seoul, Republic of KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-5429-4839View further author information
https://orcid.org/0000-0002-5429-4839View further author information show all